Downloadable Slidesets

Share

Program Content

Activities

  • First-line Therapy: Favorable-Risk RCC
    Planning First-line Treatment for Favorable-Risk Patients With Advanced RCC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 13, 2020

    Expires: February 11, 2021

  • First-line Therapy: Intermediate-/Poor-Risk RCC
    First-line Management of Advanced RCC With IMDC Intermediate-/Poor-Risk Disease
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 13, 2020

    Expires: February 11, 2021

  • Second-line Therapy and Beyond: RCC
    Optimal Treatment for Patients With RCC After Previous Therapy
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 13, 2020

    Expires: February 11, 2021

Faculty

cover img faculity

Brian A. Costello, MD, MS

Associate Professor of Oncology and Urology
Consultant

Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Martin H. Voss, MD

Attending Physician
Division of GU Medical Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
Assistant Professor

Weill Cornell Medical College
New York, New York

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from
Eisai
Pfizer and EMD Serono

Supported by a medical education grant from
Exelixis, Inc.
Supported by an independent educational grant from

Merck Oncology

Partners

Clinical Care Options, LLC

ProCE Banner